News | June 23, 2026
WuXi Biologics wins fourth EMA certification for Suzhou Biosafety Center
Clearing 19 biologics for Europe market
Clearing 19 biologics for Europe market
The move comes as demand rises for wider access to glaucoma screening and more flexible clinical workflows
The incubator anchored at the company's global headquarters in Raleighla launches alongside an inaugural partnership with Cape Fear BioCapital, a Durham-based seed-stage venture capital firm
As per the company’s Restated H1 2025 Financials, its continuing business delivered CORE EBITDA of CHF 922 million, representing a margin of 30.4%
The company reported consolidated revenue of Rs. 172.9 crore and EBITDA of Rs 25.9 crore in FY26
As per union government, growing public participation reflects rising awareness and collective commitment towards advancing organ and tissue donation
Initiative seeks innovative experimental and computational approaches to uncover neural circuits regulating immune function and identify novel therapeutic targets
The company said the safety profile remained consistent with earlier studies and was considered manageable
The research underscores growing concern that the intersection of neurodevelopmental conditions and social disadvantage can significantly compound health risks across the life course
Under the agreement, Apogee shareholders will receive $135.11 per share in cash, and the transaction has been unanimously approved by both companies’ boards
Subscribe To Our Newsletter & Stay Updated
